Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Srx246
1. Srx246
2. 512784-93-9
3. Srx 246
4. 372x2p22uy
5. Dtxsid701032257
6. Refchem:185218
7. Dtxcid001517266
8. (alphar)-gamma-oxo-alpha-((3s,4r)-2-oxo-3-((4s)-2-oxo-4-phenyl-3-oxazolidinyl)-4-((1e)-2-phenylethenyl)-1-azetidinyl)-n-((1r)-1-phenylethyl)(1,4'-bipiperidine)-1'-butanamide
9. (1,4'-bipiperidine)-1'-butanamide, Gamma-oxo-alpha-((3s,4r)-2-oxo-3-((4s)-2-oxo-4-phenyl-3-oxazolidinyl)-4-((1e)-2-phenylethenyl)-1-azetidinyl)-n-((1r)-1-phenylethyl)-, (alphar)-
10. Gamma-oxo-alpha-((3s,4r)-2-oxo-3-((4s)-2-oxo-4-phenyl-3-oxazolidinyl)-4-((1e)-2-phenylethenyl)-1-azetidinyl)-n-((1r)-1-phenylethyl)-(alphar)-(1,4'-bipiperidine)-1'-butanamide
11. (2r)-4-oxo-2-((3s,4r)-2-oxo-3-((4s)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl)-4-((1e)-2-phenylethenyl)azetidin-1-yl)-n-((1s)-1-phenylethyl)-4-(4-(2-(piperidin-1-yl)ethyl)piperidin-1-yl)butanamide
12. Unii-372x2p22uy
13. Chembl395817
14. (2r)-4-oxo-2-[(3s,4r)-2-oxo-3-[(4s)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-4-[(e)-2-phenylethenyl]azetidin-1-yl]-n-[(1r)-1-phenylethyl]-4-(4-piperidin-1-ylpiperidin-1-yl)butanamide
15. Orb1706602
16. Schembl14198966
17. Bdbm50202920
18. Ex-a12241
19. Nsc782566
20. Akos040742647
21. Nsc-782566
22. Da-58079
23. Ms-31178
24. Hy-105685
25. Cs-0026445
26. G17232
27. (.alpha.r)-.gamma.-oxo-.alpha.-((3s,4r)-2-oxo-3-((4s)-2-oxo-4-phenyl-3-oxazolidinyl)-4-((1e)-2-phenylethenyl)-1-azetidinyl)-n-((1r)-1-phenylethyl)(1,4'-bipiperidine)-1'-butanamide
28. (1,4'-bipiperidine)-1'-butanamide, .gamma.-oxo-.alpha.-((3s,4r)-2-oxo-3-((4s)-2-oxo-4-phenyl-3-oxazolidinyl)-4-((1e)-2-phenylethenyl)-1-azetidinyl)-n-((1r)-1-phenylethyl)-, (.alpha.r)-
29. .gamma.-oxo-.alpha.-((3s,4r)-2-oxo-3-((4s)-2-oxo-4-phenyl-3-oxazolidinyl)-4-((1e)-2-phenylethenyl)-1-azetidinyl)-n-((1r)-1-phenylethyl)-(.alpha.r)-(1,4'-bipiperidine)-1'-butanamide
30. 2(r)-[[4-(piperidin-1-yl)piperidin-1-yl]carbonylmethyl]-2-[3(s)-(4(s)-phenyloxazolidin-2-on-3-yl)-4(r)-(2-styryl)azetidin-2-on-1-yl]acetic Acid N-[(r)-alpha-methylbenzyl]amide
| Molecular Weight | 703.9 g/mol |
|---|---|
| Molecular Formula | C42H49N5O5 |
| XLogP3 | 5.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 11 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 103 |
| Heavy Atom Count | 52 |
| Formal Charge | 0 |
| Complexity | 1260 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antidiuretic Hormone Receptor Antagonists
Endogenous compounds and drugs that inhibit or block the activity of ANTIDUIRETIC HORMONE RECEPTORS.
ABOUT THIS PAGE
21
PharmaCompass offers a list of Srx-246 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Srx-246 manufacturer or Srx-246 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Srx-246 manufacturer or Srx-246 supplier.
A SRX 246 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of SRX 246, including repackagers and relabelers. The FDA regulates SRX 246 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. SRX 246 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A SRX 246 supplier is an individual or a company that provides SRX 246 active pharmaceutical ingredient (API) or SRX 246 finished formulations upon request. The SRX 246 suppliers may include SRX 246 API manufacturers, exporters, distributors and traders.
SRX 246 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of SRX 246 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right SRX 246 GMP manufacturer or SRX 246 GMP API supplier for your needs.
A SRX 246 CoA (Certificate of Analysis) is a formal document that attests to SRX 246's compliance with SRX 246 specifications and serves as a tool for batch-level quality control.
SRX 246 CoA mostly includes findings from lab analyses of a specific batch. For each SRX 246 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
SRX 246 may be tested according to a variety of international standards, such as European Pharmacopoeia (SRX 246 EP), SRX 246 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (SRX 246 USP).